AlphaMadera's AlphaVal page classifies Global Medical REIT Inc. as a Real Estate Investment Trust business and values it using P/FFO × Healthcare REIT Multiple, then compares the result to the current market price to flag GMRE as undervalued, fairly valued, or overvalued.

What is Global Medical REIT Inc.'s fair value?

Fair value for GMRE comes from a P/FFO × Healthcare REIT Multiple model -- the approach AlphaVal selected for this company's Real Estate Investment Trust classification. The live AlphaVal page shows bear, base, and bull scenarios alongside the key assumption behind each.

How does AlphaMadera value GMRE?

AlphaVal routes each company to one of ten valuation archetypes based on its business model. GMRE was classified as Real Estate Investment Trust and is valued using P/FFO × Healthcare REIT Multiple, built from GMRE's most recent reported fundamentals.

GMRE - Global Medical REIT Inc.

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $20.92 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Real Estate Investment Trust 85% confidence

Primary model: P/FFO × Healthcare REIT Multiple

Valuation Signal Undervalued Strong

Trading 46.6% below fair value

Current Price $35.74

Bear Case $52.02 45.5% upside ($52.02 - $35.74) / $35.74 = 45.5% $3.43 FFO × 15x

Fair Value $66.88 87.1% upside ($66.88 - $35.74) / $35.74 = 87.1% $3.43 FFO × 19x

Bull Case $81.74 128.7% upside ($81.74 - $35.74) / $35.74 = 128.7% $3.43 FFO × 24x

Adjust Assumptions

P/FFO Multiple

19.5x

FFO per Share

3.43$

Key Value Driver

FFO/share ($3.43) × healthcare P/FFO multiple

Terminal Value % of EV

Implied Market Multiple 10.4x

Market is pricing in (growth)

Plain-Language Summary

At $3.43 FFO/share with a 19x healthcare REIT multiple, the base-case value is $66.88 per share. Dividend yield: 4.2%.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (22 analysts) $20.92

Analyst Range $11.00 – $40.00

Divergence from AlphaVal 220%

Warnings

⚠ Standard profit figures are misleading for real estate companies — large non-cash accounting charges make profits look artificially low. Dividend yield and funds from operations are better measures.

ℹ Wall Street's average price target is $20.92 (from 22 analysts). Our estimate is 220% above the consensus -- consider that gap carefully.

Key Risks

P/E and EV/EBITDA are structurally wrong for REITs — use P/FFO and NAV
Interest rate sensitivity: REIT multiples compress when rates rise
FFO approximation (NI + D&A) may include gains on property sales — verify